As of 2026-03-08, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -4.45 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 42.82 USD, the upside of Terns Pharmaceuticals Inc is -110.38%.
Based on its market price of 42.82 USD and our intrinsic valuation, Terns Pharmaceuticals Inc (TERN) is overvalued by 110.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.45 - -4.45 | -4.45 | -110.38% |
| P/E | (17.18) - (17.62) | (17.38) | -140.6% |
| DDM - Stable | (8.27) - (27.20) | (17.74) | -141.4% |
| DDM - Multi | (0.27) - (0.67) | (0.38) | -100.9% |
| Market Cap (mil) | 4,547.48 |
| Beta | 0.80 |
| Outstanding shares (mil) | 106.20 |
| Enterprise Value (mil) | 4,396.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.23% |
| Cost of Debt | 5.00% |
| WACC | 7.10% |